Bioengineers at EPFL have created miniature intestines in a dish that match up anatomically and functionally to the real thing better than any other lab-grown tissue models. The biological complexity and longevity of the new organoid technology is an important step towards enabling drug testing, personalized medicine, and perhaps, one day, transplantations.
Organoids are fast-becoming one of the most cutting-edge tools of modern life sciences. The idea is to use stem cells to build miniature tissues and organs that accurately resemble and behave like their real counterparts.
One can immediately appreciate the value of organoids for both research and medicine: from basic biological research to drug development and testing, organoids could complement animal testing by providing healthy or diseased human tissues, expediting the lengthy journey from lab to clinical trial. Beyond that, there is already the whisper of organoid technology perhaps being used for replacing damaged tissues or even organs in the future: take stems cells from the patient and grow them into a new liver, heart, kidney, or lung.
So far, established methods of making organoids come with considerable drawbacks: stem cells develop uncontrollably into circular and closed tissues that have a short lifespan, as well as non-physiological size and shape, all of which result in overall anatomical and/or physiological inconsistency with real-life organs.
Now, scientists from the group led by Matthias Lütolf at EPFL‘s Institute of Bioengineering have found a way to “guide” stem cells to form an intestinal organoid that looks and functions just like a real tissue. Published in Nature, the method exploits the ability of stem cells to grow and organize themselves along a tube-shaped scaffold that mimics the surface of the native tissue, placed inside a microfluidic chip (a chip with little channels in which small amounts of fluids can be precisely manipulated).
The EPFL researchers used a laser to sculpt this gut-shaped scaffold within a hydrogel, a soft mix of crosslinked proteins found in the gut’s extracellular matrix supporting the cells in the native tissue. Aside from being the substrate on which the stem cells could grow, the hydrogel thus also provides the form or “geometry” that would build the final intestinal tissue.
Once seeded in the gut-like scaffold, within hours, the stem cells spread across the scaffold, forming a continuous layer of cells with its characteristic crypt structures and villus-like domains. Then came the surprise: the scientists found that, the stem cells just “knew” how to arrange themselves in order to form a functional tiny gut.
“It looks like the geometry of the hydrogel scaffold, with its crypt-shaped cavities, directly influences the behavior of the stem cells so that they are maintained in the cavities and differentiate in the areas outside, just like in the native tissue,” says Lütolf. The stem cells didn’t just adopt to the shape of the scaffold, they produced all the key differentiated cell types found in the real gut, with some rare and specialized cell types normally not found in organoids.
Intestinal tissues are known for the highest cell turnover rates in the body, resulting in a massive amount of shed dead cells accumulating in the lumen of the classical organoids that grow as closed spheres and require weekly breaking down into small fragments to maintain them in culture. “The introduction of a microfluidic system allowed us to efficiently perfuse these mini-guts and establish a long-lived homeostatic organoid system in which cell birth and death are balanced,” says Mike Nikolaev, the first author of the paper.
The researchers demonstrate that these miniature intestines share many functional features with their in vivo counterparts. For example, they can regenerate after massive tissue damage and they can be used to model inflammatory processes or host-microbe interactions in a way not previously possible with any other tissue model grown in the laboratory.
In addition, this approach is broadly applicable for the growth of miniature tissues from stem cells derived from other organs such as the lung, liver or pancreas, and from biopsies of human patients. “Our work shows that tissue engineering can be used to control organoid development and build next-gen organoids with high physiological relevance, opening up exciting perspectives for disease modelling, drug discovery, diagnostics and regenerative medicine,” says Lütolf.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Lustgarten Foundation Receives $424,000 Grant Establishing the Gail V. Coleman and Kenneth M. Bruntel Organoids for Personalized Therapy Projecton March 3, 2021 at 11:28 am
Devastated by the loss of her husband Kenneth Bruntel to pancreatic cancer, Gail Coleman is laser-focused on funding research offering hope ...
- Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumourson March 3, 2021 at 9:59 am
Malignant rhabdoid tumours (MRT) have been suggested to originate in the ectoderm-derived neural crest. Here, the authors analyse MRTs using phylogenetics, scRNA-seq, and patient-derived organoids; ...
- Asia Pacific organoids market: A new window into disease, development and discovery 2027on March 2, 2021 at 10:22 pm
Asia Pacific organoids market is expected to reach US 513 74 Million in 2027 from US 97 02 Million in 2019 The market is estimated to grow with a CAGR of 23 1 from 2020 2027 Key driving factor such ...
- The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019on February 26, 2021 at 11:06 am
The market is estimated to grow at a CAGR of 22. 1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing ...
- Outlook on the Organoids and Spheroids Global Market to 2028 - by Type, Application, End-use and Regionon February 25, 2021 at 3:30 am
The "Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By End-Use; By Regions; ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- FMI’s Study Highlights Accelerating Sales of 3D Printed Medical Devices at Double-digit CAGRon February 25, 2021 at 10:19 pm
As the medical industry continues to leverage the power of additive software and hardware in optimizing the design of prosthetics and instruments, the 3D printed medical devices market is expected to ...
- Demand for Cardiac Assist Devices on Upswing, Integration of Internet of Things (IoT) Underway, Finds FMIon February 25, 2021 at 10:16 pm
The global market for cardiac assist devices is expected to reach a remarkable net worth of US$ 37 Bn by the end of 2029, incrementing at a CAGR of 5.7% over the forecast period 2019-2029. High ...
- An organoid-based organ-repurposing approach to treat short bowel syndromeon February 24, 2021 at 12:03 pm
Organoid technology enables an efficient expansion of intestinal epithelium tissue in vitro 1, but reconstruction of the whole small intestine, including the complex lymphovascular system ...
- Over 1-year-old Lab Grown Miniature Brain Mimics Real Life Situationon February 24, 2021 at 3:39 am
A team of researchers from UCLA and Stanford University has grown a brain organoid from human stem cells for more than a year (20 months) and found that the stem-cell derived brain organoid behaves in ...
- Organoids Market is projected to grow at a Significant CAGR of ~ 15% during 2019 to 2029 – Future Market Insightson February 22, 2021 at 5:22 am
Additionally, increasing bio-banking activity in the region is anticipated to propel the organoid market growth. Furthermore, rising research and development in 3D cell culture technology, prominent ...